The Hippo pathway effector YAP is an essential regulator of ductal progenitor patterning in the mouse submandibular gland

  1. Aleksander D Szymaniak
  2. Rongjuan Mi
  3. Shannon E McCarthy
  4. Adam C Gower
  5. Taylor L Reynolds
  6. Michael Mingueneau
  7. Maria Kukuruzinska
  8. Xaralabos Varelas  Is a corresponding author
  1. Boston University School of Medicine, United States
  2. Biogen, United States
  3. Boston University School of Dental Medicine, United States

Abstract

Salivary glands, such as submandibular glands (SMGs), are composed of branched epithelial ductal networks that terminate in acini that together produce, transport and secrete saliva. Here, we show that the transcriptional regulator Yap, a key effector of the Hippo pathway, is required for the proper patterning and morphogenesis of SMG epithelium. Epithelial deletion of Yap in developing SMGs results in the loss of ductal structures, arising from reduced expression of the EGF family member Epiregulin, which we show is required for the expansion of Krt5/Krt14-positive ductal progenitors. We further show that epithelial deletion of the Lats1 and Lats2 genes, which encode kinases that restrict nuclear Yap localization, results in morphogenesis defects accompanied by an expansion of Krt5/Krt14-positive cells. Collectively, our data indicate that Yap-induced Epiregulin signaling promotes the identity of SMG ductal progenitors and that removal of nuclear Yap by Lats1/2-mediated signaling is critical for proper ductal maturation.

Data availability

The following data sets were generated

Article and author information

Author details

  1. Aleksander D Szymaniak

    Department of Biochemistry, Boston University School of Medicine, Boston, United States
    Competing interests
    No competing interests declared.
  2. Rongjuan Mi

    Department of Biochemistry, Boston University School of Medicine, Boston, United States
    Competing interests
    No competing interests declared.
  3. Shannon E McCarthy

    Department of Biochemistry, Boston University School of Medicine, Boston, United States
    Competing interests
    No competing interests declared.
  4. Adam C Gower

    Boston University Clinical and Translational Science Institute, Boston University School of Medicine, Boston, United States
    Competing interests
    No competing interests declared.
  5. Taylor L Reynolds

    Immunology Research, Biogen, Cambridge, United States
    Competing interests
    Taylor L Reynolds, Employee of Biogen.
  6. Michael Mingueneau

    Immunology Research, Biogen, Cambridge, United States
    Competing interests
    Michael Mingueneau, Employee of Biogen.
  7. Maria Kukuruzinska

    Department of Molecular and Cell Biology, Boston University School of Dental Medicine, Boston, United States
    Competing interests
    No competing interests declared.
  8. Xaralabos Varelas

    Department of Biochemistry, Boston University School of Medicine, Boston, United States
    For correspondence
    xvarelas@bu.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2882-4541

Funding

March of Dimes Foundation (1-FY14-219)

  • Xaralabos Varelas

National Heart, Lung, and Blood Institute (R01 HL124392)

  • Xaralabos Varelas

Sjogren's Syndrome Foundation (Research Grant)

  • Xaralabos Varelas

National Institute of Dental and Craniofacial Research (R21 DE024954)

  • Maria Kukuruzinska

National Center for Advancing Translational Sciences (UL1-TR001430)

  • Adam C Gower
  • Xaralabos Varelas

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health.Animal care and handling was consistent with the recommendations of the Panel on Euthanasia of the American Veterinary Medical Association. Prior to the initiation of experiments, all study protocols were reviewed and modified according to the suggestions of the Boston University School of Medicine IACUC. The Boston University School of Medicine animal management program is accredited by the American Association for the Accreditation of Laboratory Animal Care, and meets National Institutes of Health standards as set forth in the Guide for the Care and Use of Laboratory Animals (DHHS Pub.No. (NIH) 85-23, rev 1985). Boston University's Animal Welfare Assurance number is A-3316-01.

Copyright

© 2017, Szymaniak et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,260
    views
  • 512
    downloads
  • 42
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Aleksander D Szymaniak
  2. Rongjuan Mi
  3. Shannon E McCarthy
  4. Adam C Gower
  5. Taylor L Reynolds
  6. Michael Mingueneau
  7. Maria Kukuruzinska
  8. Xaralabos Varelas
(2017)
The Hippo pathway effector YAP is an essential regulator of ductal progenitor patterning in the mouse submandibular gland
eLife 6:e23499.
https://doi.org/10.7554/eLife.23499

Share this article

https://doi.org/10.7554/eLife.23499

Further reading

    1. Cancer Biology
    2. Developmental Biology
    Sara Jaber, Eliana Eldawra ... Franck Toledo
    Research Article

    Missense ‘hotspot’ mutations localized in six p53 codons account for 20% of TP53 mutations in human cancers. Hotspot p53 mutants have lost the tumor suppressive functions of the wildtype protein, but whether and how they may gain additional functions promoting tumorigenesis remain controversial. Here, we generated Trp53Y217C, a mouse model of the human hotspot mutant TP53Y220C. DNA damage responses were lost in Trp53Y217C/Y217C (Trp53YC/YC) cells, and Trp53YC/YC fibroblasts exhibited increased chromosome instability compared to Trp53-/- cells. Furthermore, Trp53YC/YC male mice died earlier than Trp53-/- males, with more aggressive thymic lymphomas. This correlated with an increased expression of inflammation-related genes in Trp53YC/YC thymic cells compared to Trp53-/- cells. Surprisingly, we recovered only one Trp53YC/YC female for 22 Trp53YC/YC males at weaning, a skewed distribution explained by a high frequency of Trp53YC/YC female embryos with exencephaly and the death of most Trp53YC/YC female neonates. Strikingly, however, when we treated pregnant females with the anti-inflammatory drug supformin (LCC-12), we observed a fivefold increase in the proportion of viable Trp53YC/YC weaned females in their progeny. Together, these data suggest that the p53Y217C mutation not only abrogates wildtype p53 functions but also promotes inflammation, with oncogenic effects in males and teratogenic effects in females.

    1. Developmental Biology
    Mengjie Li, Aiguo Tian, Jin Jiang
    Research Advance

    Stem cell self-renewal often relies on asymmetric fate determination governed by niche signals and/or cell-intrinsic factors but how these regulatory mechanisms cooperate to promote asymmetric fate decision remains poorly understood. In adult Drosophila midgut, asymmetric Notch (N) signaling inhibits intestinal stem cell (ISC) self-renewal by promoting ISC differentiation into enteroblast (EB). We have previously shown that epithelium-derived Bone Morphogenetic Protein (BMP) promotes ISC self-renewal by antagonizing N pathway activity (Tian and Jiang, 2014). Here, we show that loss of BMP signaling results in ectopic N pathway activity even when the N ligand Delta (Dl) is depleted, and that the N inhibitor Numb acts in parallel with BMP signaling to ensure a robust ISC self-renewal program. Although Numb is asymmetrically segregated in about 80% of dividing ISCs, its activity is largely dispensable for ISC fate determination under normal homeostasis. However, Numb becomes crucial for ISC self-renewal when BMP signaling is compromised. Whereas neither Mad RNA interference nor its hypomorphic mutation led to ISC loss, inactivation of Numb in these backgrounds resulted in stem cell loss due to precocious ISC-to-EB differentiation. Furthermore, we find that numb mutations resulted in stem cell loss during midgut regeneration in response to epithelial damage that causes fluctuation in BMP pathway activity, suggesting that the asymmetrical segregation of Numb into the future ISC may provide a fail-save mechanism for ISC self-renewal by offsetting BMP pathway fluctuation, which is important for ISC maintenance in regenerative guts.